Direct Thrombin Inhibitors May Pose Increased Risk of MI

Dabigatran became more widely prescribed for patients with non-valvular AF after initially showing superiority to warfarin in the RE-LY trial. Results of subsequent analyses, however, dictate caution.
Source: Consultant Live - Category: Primary Care Source Type: news